|
KMID : 0191120140290081090
|
|
Journal of Korean Medical Science
2014 Volume.29 No. 8 p.1090 ~ p.1093
|
|
|
Follow-up Testing of Interferon-Gamma Release Assays Are Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor Necrosis Factor Alpha for Latent Tuberculosis Infection
|
|
Son Chang-Nam
Jun Hey-Jung
Kim Jong-Heon
Sung Il-Hoon
Yoo Dae-Hyun
Kim Tae-Hwan
|
|
|
Abstract
|
|
|
|
We evaluated the utility of follow-up interferon-gamma release assays (IGRAs) for the diagnosis of reactivation of latent tuberculosis infection (LTBI) or new tuberculosis in ankylosing spondylitis (AS) patients receiving anti-tumor necrosis factor alpha (anti-TNFα). The study participants (n=127) had a negative IGRA screening before receiving anti-TNFα and were evaluated by follow-up IGRA. We retrospectively examined data of the subjects according to age, gender, tuberculosis prophylaxis, concomitant medications, IGRA conversion and anti-TNFα, including type and treatment duration. The median duration of anti-TNFα was 21.5 months, and the median age was 35.3 yr. Of the 127 patients, IGRA conversion was found in 10 patients (7.9%). There was no significant variation between IGRA conversion rate and any risk factors except for age. IGRA conversion rate was not significantly different between AS and rheumatoid arthritis (P=0.12). IGRA conversion was observed in AS patients receiving anti-TNFα in Korea. A follow-up IGRA test can be helpful for identifying LTBI or new tuberculosis in AS patients receiving anti-TNFα.
|
|
|
KEYWORD
|
|
|
Ankylosing Spondylitis, Interferon-Gamma Release Assay, Anti-Tumor Necrosis Factor, Latent Tuberculosis Infection
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|